83P A fully-automated integrative workflow to support clinical decisions in molecular tumour boards
Mauro Giovanni Carta(University of Cagliari), Fulvia Ferrazzi(Friedrich-Alexander-Universität Erlangen-Nürnberg), Simona Vatrano(European Gravitational Observatory), Davide Rizzi(Tethys Research Institute), Christoph D. Schubart(University of Regensburg), Florian Haller(Universitätsklinikum Erlangen), Paolo Magni(University of Pavia), M. Angeloni(Universitätsklinikum Erlangen), Annett Hölsken(Comprehensive Cancer Center Erlangen), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Filippo Fraggetta, Lars Tögel(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 0
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS
|Deutsches Ärzteblatt international|2020|258
The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing
|Molecular Cancer Research|2010|227
Adjustment Disorder: epidemiology, diagnosis and treatment
|Clinical Practice and Epidemiology in Mental Health|2009|190